Evidence map›Paper›PMID 36623537›Full record

ArticleThe lancet. HIV2023

Associations between punitive policies and legal barriers to consensual same-sex sexual acts and HIV among gay men and other men who have sex with men in sub-Saharan Africa: a multicountry, respondent-driven sampling survey.

Carrie E Lyons, Jean Olivier Twahirwa Rwema, Keletso Makofane, Daouda Diouf, Iliassou Mfochive Njindam, Ibrahima Ba, Abo Kouame, Ubald Tamoufe, Bai Cham, Mamadú Aliu Djaló and 13 more

Open access · greenAbstract read
In one paragraph

Article in The lancet. HIV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Global Legal Environment for LGBTQ+ Sexuality and Public Health.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Beating the odds: medicines alone will not stop HIV.Journal of the International AIDS Society · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 6 countries.

Carrie E LyonsDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA. Electronic address: clyons8@jhmi.edu.
Jean Olivier Twahirwa RwemaDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Keletso MakofaneFXB Health and Human Rights, Harvard T H Chan School of Public Health, Boston, MA, USA.
Daouda DioufEnda Sante, Dakar, Senegal.
Iliassou Mfochive NjindamDepartment of Epidemiology, Johns Hopkins School of Public Health, Yaoundé, Cameroon.
Ibrahima BaEnda Sante, Dakar, Senegal.
Abo KouameMinistère de la Santé et de l'Hygiène Publique, Abidjan, Côte d'Ivoire.
Ubald TamoufeJohns Hopkins Cameroon Program/Metabiota, Yaoundé, Cameroon.
Bai ChamActionaid, Banjul, The Gambia.
Mamadú Aliu DjalóEnda Santé Guinéa-Bissau, Bissau, Guinea-Bissau.
Evelyne-Patrice ObodouEnda Santé Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Etienne KaritaProjet San Francisco, Kigali, Rwanda.
Anato SimpliceONG Arc-en-Ciel, Lomé, Togo.
Rebecca G NowakInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Trevor A CrowellInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
Sindy MatseEswatini Ministry of Health, Mbabane, Eswatini.
Seni KouandaInstitut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Institut Africain de Santé Publique, Ouagadougou, Burkina Faso.
Jean-Paul EnamaHumanity First, Yaoundé, Cameroon.
Matthew KavanaghDepartment of International Health and Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA.
Gregorio A MillettamfAR, The Foundation for AIDS Research, Washington, DC, USA.
Chris BeyrerDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA; Duke Global Health Institute, Duke University, Durham, NC, USA.
Sarah MurrayDepartment of Mental Health, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Stefan BaralDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Johns Hopkins University · USEnvironment and Development Action Third World · SNAmerican Foundation for AIDS Research · USDuke Institute for Health Innovation · USGeorgetown University · USHarvard University · USInstitut de Recherche en Sciences de la Santé · BFMetabiota (Cameroon) · CMMinistère de la Santé et de l'Hygiène Publique · CIMinistry of Health · SZUniversity of Maryland, Baltimore · USWalter Reed Army Institute of Research · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Validation of Stigma Metrics for Marginalized Men R01MH110358 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2017 to 2021
$3.6M
Leveraging Big Data Science to Focus the HIV Response in Countries with Generalized HIV EpidemicsR01AI170249 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2022 to 2025
$2.9M
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirusK07CA225403 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI NOWAK, REBECCA G. · 2018 to 2022
$677k
Understanding multilevel barriers and facilitators to HIV treatment among marginalized women living with HIV in the context of intersecting HIV, TB, and COVID-19 pandemicsF31MH128079 · NIMH · JOHNS HOPKINS UNIVERSITY · PI LYONS, CARRIE ELIZABETH · 2022 to 2023
$61k
NCI NIH HHS K07 CA225403NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI170249NIAID NIH HHS T32 AI102623NIMH NIH HHS F31 MH128079NIMH NIH HHS R01 MH110358
6 · The paper itself

Abstract

backgroundFew assessments of associations between structural-level factors and HIV among gay men and other men who have sex with men (MSM) have been conducted, especially in sub-Saharan Africa. Our objective was to examine HIV testing history, HIV status, and stigmas among MSM living in ten countries with heterogeneous legal environments.

methodsThis study used pooled data from ten country-specific, cross-sectional studies done in 25 sites in Burkina Faso, Cameroon, Côte d'Ivoire, The Gambia, Guinea-Bissau, Nigeria, Senegal, Eswatini, Rwanda, and Togo. MSM were recruited by respondent-driven sampling and were eligible if they met country-specific requirements for age, area of residence, and self reported being assigned male sex at birth and having anal sex with a man in the past 12 months. Policy related to same-sex sexual behaviour for each country was categorised as not criminalised or criminalised. Countries were also categorised on the basis of recent reports of prosecutions related to same-sex sexual acts. Legal barriers were defined as those that legally prevented registration or operation of sexual orientation related civil society organisations (CSOs). Individual data on HIV testing history, HIV status, and stigma were collected via interviewer-administered sociobehavioural questionnaires and HIV testing. Multilevel logistic regression with random intercepts was used to assess the association between policies, recent prosecutions, legal barriers to CSOs, and HIV-related factors with adjusted odds ratios (aORs) and 95% CIs.

findingsBetween Aug 3, 2011, and May 27, 2020, we recruited 8047 MSM with a median age of 23 years (IQR 21-27). 4886 (60·7%) lived in countries that criminalise same-sex sexual acts. HIV prevalence among MSM was higher in criminalised settings than non-criminalised settings (aOR 5·15, 95% CI 1·12-23·57); higher in settings with recent prosecutions than in settings without prosecutions (12·06, 7·19-20·25); and higher in settings with barriers to CSOs than without barriers to CSOs (9·83, 2·00-48·30). HIV testing or status awareness was not associated with punitive policies or practices. Stigma was associated with HIV status but did not consistently vary across legal environments. Disparities in HIV prevalence between MSM and other adult men were highest in punitive settings.

interpretationStructural risks including discriminatory country-level policies, prosecutions, and legal barriers might contribute to higher HIV prevalence among MSM. Taken together, these data highlight the importance of decriminalisation and decreasing enforcement, alongside stigma reduction, as central to effective control for HIV.

fundingNational Institutes of Health. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.

Indexed as

HIV InfectionsSexual and Gender MinoritiesAdultAfrica, CentralAfrica, WesternCriminal BehaviorCross-Sectional StudiesFemaleHomosexuality, MaleHumansMaleSexual BehaviorSurveys and QuestionnairesYoung Adult

Identifiers

PMID36623537
PMCPMC10288909
OpenAlexW4313621181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.